Trials / Sponsors / Thomas Hatschek
Thomas Hatschek
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors Early-Stage Breast Carcinoma, Hormone Receptor Positive Tumor | Phase 2 | 2015-10-01 |
| Active Not Recruiting | Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor | Phase 2 | 2015-02-01 |
| Active Not Recruiting | Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer | Phase 2 / Phase 3 | 2014-11-01 |
| Unknown | A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatmen Breast Cancer | Phase 2 | 2008-09-01 |
| Completed | Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Ca Metastatic Breast Cancer | Phase 3 | 2002-12-01 |